Explore the Potential with AI-Driven Innovation
The focused library is created on demand with the latest virtual screening and parameter assessment technology, supported by the Receptor.AI drug discovery platform. This method is more effective than traditional methods and results in higher-quality compounds with better activity, selectivity, and safety.
The compounds are cherry-picked from the vast virtual chemical space of over 60B molecules. The synthesis and delivery of compounds is facilitated by our partner Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q7Z4T8
UPID:
GLTL5_HUMAN
Alternative names:
Polypeptide GalNAc transferase 15; Protein-UDP acetylgalactosaminyltransferase 15; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 15
Alternative UPACC:
Q7Z4T8; Q75KN2; Q75MD3; Q8NCV4; Q8WW05; Q9UDR9
Background:
Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5, also known as Polypeptide GalNAc transferase 15, plays a crucial role in spermatid development. It is believed to be involved in protein loading into the acrosomes and supports the accumulation of ubiquitin-proteasome systems around the head-tail coupling apparatus region.
Therapeutic significance:
Understanding the role of Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 could open doors to potential therapeutic strategies, particularly in the realm of reproductive health and fertility treatments.